Cleared Traditional

K151639 - ABL80 FLEX and ABL80 FLEX CO-OX

K151639 is the FDA 510(k) clearance for ABL80 FLEX and ABL80 FLEX CO-OX by Sendx Medical, Inc.. It is a Class 2 Chemistry device (product code CGA) cleared through the Traditional 510(k) pathway after a 172-day FDA review.

K151639 · Sendx Medical, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2015
Decision
172d
Days
Class 2
Risk

K151639 is an FDA 510(k) clearance for the ABL80 FLEX and ABL80 FLEX CO-OX. Classified as Glucose Oxidase, Glucose (product code CGA), Class II - Special Controls.

Submitted by Sendx Medical, Inc. (Carlsbad, US). The FDA issued a Cleared decision on December 7, 2015 after a review of 172 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Sendx Medical, Inc. devices

Submission Details

510(k) Number K151639 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 18, 2015
Decision Date December 07, 2015
Days to Decision 172 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
84d slower than avg
Panel avg: 88d · This submission: 172d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CGA Glucose Oxidase, Glucose
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CGA Glucose Oxidase, Glucose

All 191
Devices cleared under the same product code (CGA) and FDA review panel - the closest regulatory comparables to K151639.
VITROS Chemistry Products GLU Slides
K163433 · Ortho-Clinical Diagnostics · Sep 2017
GEM Premier 5000 (Measured Parameters:Glucose, Lactate and Total Bilirubin)
K160402 · Instrumentation Laboratory CO · Dec 2016
GEM Premier 3000
K161818 · Instrumentation Laboratory CO · Sep 2016
GAL-1F Blood Glucose Monitoring System, GAL-1F Pro Blood Glucose Monitoring System
K142689 · Apex BioTechnology Corp. · Aug 2015
MEG-2B Blood Glucose Monitoring System, MEG-2B Pro Blood Glucose Monitoring System
K143750 · Apex BioTechnology Corp. · May 2015
AUTOSURE HT BLOOD GLUCOSE MONITORING SYSTEM
K131750 · Apex BioTechnology Corp. · Mar 2014